Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Published Date: 18 Feb 2023

Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

An understudied type of breast cancer poses a lurking threat

2.

Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer

3.

Testosterone recovery linked to overall survival in high-risk prostate cancer

4.

Eight Doctors Killed in Brazil's Horrifying Plane Crash

5.

Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot